UT
UTI Mid Cap Fund Direct Growth
Latest NAV
+1.01% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty Midcap 150 TRI
Expense ratio
1.15%
AUM
₹12,795 Cr
Min SIP
₹500
Min lump sum
₹5,000
1Y
+1.01%
3Y (ann.)
+10.27%
5Y (ann.)
+10.93%
Launched
Jan 2013
Where the NAV sits & how risky it is
₹334.50
52-week range
at 56%
₹334.50
Low 23 Mar 2026₹297.54
High 31 Aug 2026₹363.30
Risk level
Very High
Low
Very high
NAV history
03 Jan 2013
Since inception
01 Oct 2026
Returns by period
1W
-3.11%
1M
-7.18%
3M
-2.73%
6M
+9.93%
1Y
+1.01%
3Y
+10.27%
5Y
+10.93%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹500
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 98.39%
Cash & other 1.61%
Sector split
Country split
Top 5 hold 11.4%
Top 10 hold 21.1%
95 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Polycab
INE455K01017 |
Industrials Electrical Equipment & Parts |
India |
2.40%
|
+26.20% |
| 2 | PB FinTech
INE417T01026 |
Financial Services Insurance Brokers |
India |
2.37%
|
-18.06% |
| 3 | Tube Investment
INE974X01010 |
Industrials Conglomerates |
India |
2.33%
|
+18.87% |
| 4 | Max Financial Services
INE180A01020 |
Financial Services Insurance - Life |
India |
2.19%
|
-4.65% |
| 5 | Suzlon Energy
INE040H01021 |
Industrials Specialty Industrial Machinery |
India |
2.11%
|
+4.86% |
| 6 | Coforge
INE591G01025 |
Technology Information Technology Services |
India |
2.04%
|
-14.85% |
| 7 | BSE
INE118H01025 |
Financial Services Financial Data & Stock Exchanges |
India |
2.01%
|
+51.82% |
| 8 | Phoenix Mills
INE211B01039 |
Real Estate Real Estate - Diversified |
India |
1.94%
|
-5.36% |
| 9 | Federal Bank
INE171A01029 |
Financial Services Banks - Regional |
India |
1.87%
|
+17.97% |
| 10 | Ajanta Pharma
INE031B01049 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
1.85%
|
+8.97% |
About this scheme
The objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of mid cap companies. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Fund manager(s): Vishal Chopda
Exit load: Exit load of 1% if redeemed less than 1 year
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
01 Jan 2013
Lump-sum min
₹5,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 120.5 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 32.4 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 29.6 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 29.6 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 28.2 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 28.1 pts ahead of this fund